TREM: A Protein Involved in The Development of Cancer (P45408)

Target Name: Triggering receptor expressed on myeloid cells

NCBI ID: P45408

Triggering receptor expressed on myeloid cells

Other Name(s): TREM

TREM: A Protein Involved in The Development of Cancer

Triggering receptor expressed on myeloid cells (TREM) is a protein that is expressed in the myeloid cells, which are a type of white blood cell that plays a critical role in the immune system. TREM is a protein that is found on the surface of myeloid cells and is associated with the development of multiple myeloma, a type of cancer that develops from myeloid cells.

TREM is a protein that is made up of two subunits, a large transmembrane protein known as TREM-1 and a smaller cytoplasmic protein known as TREM-2. Both TREM-1 and TREM-2 are involved in the regulation of cell signaling pathways, and they are thought to play a role in the development of cancer.

One of the key functions of TREM is its role in the regulation of the activity of the T-cell receptor, a protein that is involved in the immune response. The T-cell receptor is a protein that is found on the surface of T-cells and is involved in the process of T-cell activation. TREM is thought to play a role in the regulation of the activity of the T-cell receptor by interacting with it and influencing the signaling pathways that are involved in T-cell activation.

Another function of TREM is its role in the regulation of cell signaling pathways that are involved in the development of cancer. TREM is thought to play a role in the regulation of the activity of the oncogene Bcl-2, a protein that is known to promote the growth and survival of cancer cells.

TREM is also thought to play a role in the regulation of the activity of the transcription factor NF-kappa-B, a protein that is involved in the regulation of a wide range of cellular processes. NF-kappa-B is thought to play a role in the regulation of TREM activity by interacting with it and influencing the signaling pathways that are involved in T-cell activation and cancer development.

TREM is also involved in the regulation of the activity of the protein PDGFR-尾, which is a protein that is involved in the regulation of cell signaling pathways. PDGFR-尾 is thought to play a role in the regulation of TREM activity by interacting with it and influencing the signaling pathways that are involved in T-cell activation and cancer development.

TREM is also involved in the regulation of the activity of the protein T-type tyrosine kinase, which is a protein that is involved in the regulation of cell signaling pathways. T-type tyrosine kinase is thought to play a role in the regulation of TREM activity by interacting with it and influencing the signaling pathways that are involved in T-cell activation and cancer development.

In conclusion, TREM is a protein that is expressed in myeloid cells and is involved in the regulation of a wide range of cellular processes that are important for the development and progression of cancer. TREM is thought to play a role in the regulation of the T-cell receptor, the PDGFR-尾 protein, the NF-kappa-B protein, the T-type tyrosine kinase protein, and many other proteins that are involved in the regulation of cell signaling pathways. As a result, TREM may be a promising drug target or biomarker for the development of cancer. Further research is needed to fully understand the role of TREM in the development and progression of cancer.

Protein Name: Triggering Receptor Expressed On Myeloid Cells (nonspecified Subtype)

The "Triggering receptor expressed on myeloid cells Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Triggering receptor expressed on myeloid cells comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets